home · filing · 0001493152-22-001217
8-K
filed January 14, 2022, 6:59 PM ET
ticker FEED
CIK 0001326706
leadership
confidence high
sentiment neutral
materiality 0.30
NanoVibronix appoints Aurora Cassirer and Maria Schroeder as independent directors
ENvue Medical, Inc.
Board expands from six to eight directors; six of eight now independent under Nasdaq rules.
Aurora Cassirer appointed to Compensation and Nominating & Governance Committees; 30-year attorney.
Maria Schroeder appointed to Audit Committee; CPA with CFO experience at KCI and Brain Sentinel.
Appointments effective January 13, 2022; both to serve until 2022 annual meeting.
New directors receive compensation per non-employee director policy; no material transactions disclosed.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Aurora Cassirer
Director
FEED ·
ENvue Medical, Inc.
Effective 2022-01-13
Filed January 14, 2022, 6:59 PM ET
appointed Aurora Cassirer and Maria Schroeder to the Board to serve as independent directors, effective as of January 13, 2022
Appointed
Maria Schroeder
Director
FEED ·
ENvue Medical, Inc.
Effective 2022-01-13
Filed January 14, 2022, 6:59 PM ET
appointed Aurora Cassirer and Maria Schroeder to the Board to serve as independent directors, effective as of January 13, 2022
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Aurora Cassirer was appointed as Director at ENvue Medical, Inc..
Action appointed
Role Director
Exact text from the filing
appointed Aurora Cassirer and Maria Schroeder to the Board to serve as independent directors, effective as of January 13, 2022
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Maria Schroeder was appointed as Director at ENvue Medical, Inc..
Action appointed
Role Director
Exact text from the filing
appointed Aurora Cassirer and Maria Schroeder to the Board to serve as independent directors, effective as of January 13, 2022
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-22-001217
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.